US pharmaceutical giant faces opposition in India over patent for HIV drug

A dispute is ongoing in India with a US based pharmaceutical company over a drug that’s been developed to treat HIV. Public health goups in India believe there’s a danger in the patent application, as a monopoly could be established, taking away the people’s choice.